We are live on ! Find out more
LAB icon

Standard BioTools
LAB

69 hedge funds and large institutions have $89.9M invested in Standard BioTools in 2023 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 17 increasing their positions, 16 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

66% more capital invested

Capital invested by funds: $54.2M → $89.9M (+$35.6M)

1% more funds holding

Funds holding: 68 → 69 (+1)

8% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 12

6% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 16

0.32% less ownership

Funds ownership: 58.62% → 58.31% (-0.32%)

91% less call options, than puts

Call options by funds: $22K | Put options by funds: $255K

Holders
69
Holders Change
+1
Holders Change %
+1.47%
% of All Funds
1.1%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
13
Increased
17
Reduced
16
Closed
12
Calls
$22K
Puts
$255K
Net Calls
-$233K
Net Calls Change
-$163K

Top Buyers

1
HighTower Advisors
HighTower Advisors
Illinois
+$1.06M
2
SAM
Silverback Asset Management
North Carolina
+$790K
3
Jane Street
Jane Street
New York
+$372K
4
Neuberger Berman Group
Neuberger Berman Group
New York
+$308K
5
Morgan Stanley
Morgan Stanley
New York
+$279K

Top Sellers

1
NIM
Needham Investment Management
New York
-$1.83M
2
HBWM
Hollow Brook Wealth Management
New York
-$819K
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$408K
4
CSS
Cubist Systematic Strategies
Connecticut
-$286K
5
Primecap Management
Primecap Management
California
-$235K
Name Holding Trade Value Shares
Change 		Change in
Stake
PMEF
51
Point72 Middle East FZE
United Arab Emirates
$18.2K +$18.4K +9,314 New
TRCT
52
Tower Research Capital (TRC)
New York
$12K -$34.2K -17,289 -73%
CWM
53
CarsonAllaria Wealth Management
Illinois
$7.83K – – –
PPC
54
Park Place Capital
Alabama
$5.48K – – –
BA
55
Bellwether Advisors
Nebraska
$3.93K – – –
BAM
56
Belpointe Asset Management
Nevada
$3.9K – – –
Bank of America
57
Bank of America
North Carolina
$3K +$2.19K +1,106 +255%
JP Morgan Chase
58
JP Morgan Chase
New York
$2K – – –
SSB
59
Sandy Spring Bank
Maryland
$1.95K – – –
Wells Fargo
60
Wells Fargo
California
$1.69K +$14 +7 +0.8%
AF
61
Allworth Financial
California
$1.36K +$1.38K +700 New
GRP
62
Global Retirement Partners
California
$1.32K +$1.74K +880 New
Fidelity Investments
63
Fidelity Investments
Massachusetts
$1.24K -$11.6K -5,878 -90%
ASN
64
Advisory Services Network
Georgia
$975 – – –
NA
65
NewEdge Advisors
Louisiana
$330 – – –
HGWM
66
Harvest Group Wealth Management
Massachusetts
$283 – – –
RP
67
Repertoire Partners
New York
$195 – – –
Commonwealth Equity Services
68
Commonwealth Equity Services
Massachusetts
$58 – – –
BNP Paribas Financial Markets
69
BNP Paribas Financial Markets
France
$47 -$520 -263 -92%
HBWM
70
Hollow Brook Wealth Management
New York
– -$819K -699,611 Closed
Goldman Sachs
71
Goldman Sachs
New York
– -$53K -45,273 Closed
Group One Trading
72
Group One Trading
Illinois
– -$89.1K -45,084 Closed
Prudential Financial
73
Prudential Financial
New Jersey
– -$25.5K -21,800 Closed
E
74
Ergoteles
New York
– -$21.4K -18,319 Closed
ECM
75
ExodusPoint Capital Management
New York
– -$20K -16,895 Closed
1 2
3
4

LAB Hedge Fund Activity: Q1 2023 in Review

69 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q1 2023, worth a combined $89.9M — up 66% from $54.2M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new LAB positions and 12 closed out — a net gain of 1 holder — while 17 added to existing stakes and 16 trimmed.

The largest buyer was HighTower Advisors, adding an estimated $1.06M. The largest seller was Needham Investment Management, cutting an estimated $1.83M.

  • 69 institutional investors held Standard BioTools (LAB) as of Q1 2023, up from 68 in Q4 2022.
  • Funds reported $89.9M of Standard BioTools stock for Q1 2023, up 66% quarter-over-quarter.
  • 13 funds opened new Standard BioTools positions in Q1 2023 and 12 closed out, a net change of +1 holder.
  • The largest Standard BioTools buyer in Q1 2023 was HighTower Advisors, an estimated $1.06M added.
  • The largest Standard BioTools seller in Q1 2023 was Needham Investment Management, an estimated $1.83M sold.

Based on aggregated 13F filings for Q1 2023.